Research Across America Revenue and Competitors

Dallas, TX USA

Location

N/A

Total Funding

Research

Industry

Estimated Revenue & Valuation

  • Research Across America's estimated annual revenue is currently $1.8M per year.(i)
  • Research Across America's estimated revenue per employee is $71,400

Employee Data

  • Research Across America has 25 Employees.(i)
  • Research Across America grew their employee count by -11% last year.

Research Across America's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2.7M33-17%N/AN/A
#2
$5.2M574%N/AN/A
#3
$1.8M25-11%N/AN/A
#4
$1.7M249%N/AN/A
#5
$2.1M29-3%N/AN/A
#6
$1.1M18-14%N/AN/A
#7
$3M37-18%N/AN/A
#8
$6.3M69-3%N/AN/A
#9
$32.4M2895%N/AN/A
#10
$84M6596%N/AN/A
Add Company

What Is Research Across America?

Research Across America is an Investigator Site Network (Non-SMO) with multi-specialty sites located in Texas; Dallas, TX; Plano, TX; El Paso, TX; New York, NY; Reading, PA; and their surrounding areas. The physicians affiliated with Research Across America have conducted over 1,800 clinical trials since 1992. Since that time, Research Across America has worked with most major pharmaceutical companies and contract research organizations (CROs) in a wide variety of therapeutic areas, including: Allergy/Asthma, Ear, Nose & Throat, Infectious Disease, Pain Management, Anti-infectives, Endocrinology/Obesity, Neurology Pediatrics, Cardiology, Family Practice/Internal, Medicine, Nutraceuticals, Rheumatology, Cosmeceuticals, Gastroenterology, Ophthalmology, Rx-to-OTC Switch, Dermatology, Gynecology, Orthopedics, Urology Research Across America has also conducted numerous large-scale recruitment trials involving several hundred patient volunteers for multiple-visit and OTC studies, including actual-use/consumer trials.

keywords:N/A

N/A

Total Funding

25

Number of Employees

$1.8M

Revenue (est)

-11%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.5M25N/AN/A
#2
$2.9M25N/AN/A
#3
$2.5M25N/AN/A
#4
$3.5M250%N/A
#5
$3.5M254%N/A